In acute meningitis intial managemet

Reading File
Finding Sources
Finding Sources
Searching PubMed

"bacterial meningitis" AND management

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from Harrison's 22E (2025), Bradley & Daroff's Neurology, and Rosen's Emergency Medicine. Let me compile the full answer.

Acute Meningitis: Initial Management

1. Immediate Assessment - Recognize the Syndrome

The classic triad is fever + headache + neck stiffness (nuchal rigidity). Additional features include photophobia, phonophobia, altered sensorium, and seizures. Meningococcal disease may present with a petechial/purpuric rash - this is an emergency.
"CNS infection should be considered in all patients with headache, nuchal rigidity, fever, altered sensorium, or diffuse or focal neurologic findings." - Rosen's Emergency Medicine

2. The Critical Time-Pressure Principle

Do NOT delay antibiotics for imaging or LP. Every hour of delay in antibiotic administration increases mortality.
The recommended sequence depends on clinical status:
Clinical ScenarioAction Sequence
No focal deficits, normal consciousness, no papilledemaBlood cultures → LP → Antibiotics + Dexamethasone
Focal deficits, altered consciousness, papilledema, or immunocompromisedBlood cultures → Antibiotics + Dexamethasone immediately → CT → LP
Critically ill / septic shockBlood cultures → Antibiotics + Dexamethasone (do NOT wait for anything)

3. Step-by-Step Initial Management

Step 1 - Blood Cultures

Draw 2 sets of blood cultures before any antibiotics. These take only ~2 minutes and help identify the organism even if CSF cultures are later sterilized.

Step 2 - Dexamethasone (Before or With First Antibiotic Dose)

  • Dose: 0.15 mg/kg IV q6h x 4 days (max 10 mg q6h)
  • Timing: Ideally 20 minutes before, or at least concurrent with, the first antibiotic dose
  • Proven to reduce mortality and hearing loss in pneumococcal meningitis (landmark 2002 de Gans RCT)
  • Do not start dexamethasone after antibiotics have already been given - no proven benefit
"Therapy with dexamethasone should ideally be started 20 min before, or not later than concurrent with, the first dose of antibiotics." - Harrison's Principles of Internal Medicine 22E (2025)

Step 3 - Empirical Antibiotics

Choose based on age and risk factors:
Patient GroupLikely OrganismsEmpirical Regimen
Neonates (< 1 month)Group B Strep, E. coli, Listeria, KlebsiellaAmpicillin + Cefotaxime (or Gentamicin)
Infants (1-3 months)Group B Strep, S. pneumoniae, Listeria, H. influenzaeAmpicillin + Ceftriaxone
Children & Adults (3 mo - 50 yr)S. pneumoniae, N. meningitidisCeftriaxone (2g IV q12h) + Vancomycin
Adults > 50 yr or immunocompromisedAs above + ListeriaCeftriaxone + Vancomycin + Ampicillin (2g IV q4h)
Post-neurosurgery / CSF shuntS. aureus, coag-neg Staph, PseudomonasVancomycin + Cefepime (or Meropenem)
Why vancomycin? Due to increasing penicillin-resistant S. pneumoniae globally, ceftriaxone alone is insufficient. Dexamethasone does NOT meaningfully reduce CSF vancomycin levels (Ricard 2007 study confirmed adequate CSF penetration).
"First-line treatment for healthy adults with suspected bacterial meningitis is ceftriaxone or cefotaxime plus vancomycin in most countries given high antibiotic resistance." - Rosen's Emergency Medicine

Step 4 - Lumbar Puncture (When Safe)

Perform LP for CSF analysis. LP is safe without prior CT if:
  • Normal level of consciousness
  • No focal neurologic deficits
  • No papilledema
  • No recent head trauma
  • Immunocompetent
Classic CSF findings in bacterial meningitis:
ParameterFinding
Opening pressureElevated (>180 mmH2O in 90%)
WBCPMN pleocytosis, >100 cells/μL in 90%
Glucose<40 mg/dL, CSF/serum ratio <0.4
Protein>45 mg/dL in 90%
Gram stainPositive in >60%
CulturePositive in >70%
Also send: Gram stain, C&S, glucose, protein, cell count, lactate, FilmArray PCR panel (if available - detects S. pneumoniae, N. meningitidis, HSV, and other pathogens rapidly).

Step 5 - Additional Measures

  • IV access + fluid resuscitation if signs of sepsis
  • Airway management if GCS ≤8 or rapidly deteriorating
  • Seizure management - benzodiazepines acutely; consider prophylactic levetiracetam in high-risk patients
  • ICP management if signs of raised ICP: head of bed 30°, avoid hypotonic fluids, consider mannitol 0.25-0.5 g/kg; intubation + controlled ventilation if herniation imminent
  • Aciclovir 10 mg/kg IV q8h - add empirically if HSV encephalitis is possible (altered behaviour, temporal lobe features) or when viral vs bacterial distinction is uncertain
  • Isolation precautions for suspected N. meningitidis (droplet) until 24h of effective antibiotics
  • Chemoprophylaxis for close contacts of N. meningitidis: Rifampin 600 mg PO q12h x 2 days, or single-dose Ciprofloxacin 500 mg PO, or Ceftriaxone 250 mg IM

4. Monitoring and Reassessment

  • Repeat LP at 36-48h if no clinical improvement to confirm CSF sterilization
  • Narrow antibiotics once culture and sensitivity results are available
  • Dexamethasone may be discontinued if the pathogen is NOT S. pneumoniae (less clear benefit for other organisms)
  • Monitor for complications: SIADH (fluid restrict if serum Na falls), hearing loss, hydrocephalus, subdural empyema

Summary Flow

Suspect meningitis (fever + headache + neck stiffness ± rash ± altered consciousness)
         ↓
Blood cultures × 2 immediately
         ↓
Focal deficits/papilledema/altered consciousness? 
  YES → Dexamethasone + Antibiotics NOW → CT → LP
  NO  → LP first (safe) → Dexamethasone + Antibiotics
         ↓
Adults: Ceftriaxone 2g IV q12h + Vancomycin 15-20mg/kg IV q8-12h ± Ampicillin (if >50yr)
+ Dexamethasone 0.15mg/kg IV q6h x 4 days (before/with first antibiotic dose)
         ↓
Supportive care: fluids, airway, ICP management, seizure control
+ Add Aciclovir if HSV encephalitis cannot be excluded
Sources: Harrison's Principles of Internal Medicine 22E (2025), p. 1163-1164 | Bradley and Daroff's Neurology in Clinical Practice, p. 1214-1217 | Rosen's Emergency Medicine, p. 2268
This is a shared conversation. Sign in to Orris to start your own chat.